BATON ROUGE, LA (FOX44) — Just under a year ago, Tabatha Wolfe was diagnosed with breast cancer.
"I had found it myself just doing my regular self exam. I did go and get it checked out because it seemed like it was getting worse. And it was breast cancer," remembers Wolfe.
She was all smiles Friday as she finished up her last round of radiation, but she's decided to take her fight against the disease one step further. She’s one of just a dozen battling the disease in Baton Rouge, enrolled in a new nation-wide study looking at the benefits of a drug that attacks excessive protein created by cancer cells.
"This drug, or this vaccine is trying to stimulate the immune system to attack that protein and this study is looking to see if this drug is effective," Dr. Derrick Spell, the physician overseeing the study explained.
"At first I was kind of scared because I am like, 'oh I don't know if I want to deal with any side effects. I kind of thought about the future and my daughter, and why not you know," Wolfe said when explaining her reasoning for joining the study.
Wolfe and others involved with the study will be receiving the vaccine for 3 years, she says at the end of that time she's hoping her contribution will help future generations to come.
"I would just feel great that I was able to do something to help others, and that's really my goals. And not just with breast cancer, but in life just to help others any way I can."
Doctors at the Mary Bird Perkins - Our Lady of the Lake Cancer Center have enrolled 12 participants thus far and they're looking for more. Early results of the clinical study will be available by 2015.